Probiotics stop the growth of liver cancer and reduce its volume.
Hepatocellular carcinoma constitutes 90% of cases of liver cancer, sixth tumor in frequency and second in mortality.
Liver cancer is the sixth most common type of tumor in the world and the second associated with higher mortality. A type of cancer that, in our country alone, is diagnosed each year in around 5,530 new cases, especially in men - the incidence in men practically doubles that of women - and people over 50 years of age. And a type of tumor that highlights, above all, hepatocellular carcinoma, which represents around 90% of all cases of liver cancer.
The high mortality associated with liver cancer is mainly explained by the delay in its diagnosis. It is usually that patients do not present any specific symptoms in the initial phases, the vast majority of cases are detected when the tumor has already reached an advanced stage, at which time the available treatments are not effective. However, and according to a study carried out by researchers at the University of Hong Kong (China), the intake of probiotics - that is, foods containing live microorganisms with intestinal activity - not only slows tumor growth, but which significantly decreases its volume.
Antitumor probiotics
The study was designed to evaluate the effect of a new cocktail of probiotics called 'Prohep' on cellular hepatocellular carcinoma in an animal model -ratons-. For this, the researchers fed the animals with the probiotics from the previous week or from the moment of the tumor inoculation.
Image by mundoentrenamiento.com
